$11.5B
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | ASND Ascendis Pharma A/S | 10.3M | — | $2.7B | 23.8% |
| 2 | PBLS Parabilis Medicines Inc | 28.9M | — | $792M | 6.9% |
| 3 | RYTM Rhythm Pharmaceuticals Inc | 6.7M | +0.0% | $740M | 6.4% |
| 4 | PCVX Vaxcyte Inc | 11.5M | +0.0% | $667M | 5.8% |
| 5 | SION Sionna Therapeutics Inc | 9.9M | +0.0% | $436M | 3.8% |
| 6 | TYRA Tyra Biosciences Inc | 12.2M | +0.0% | $390M | 3.4% |
| 7 | EWTX Edgewise Therapeutics Inc | 8.4M | −19.5% | $341M | 3.0% |
| 8 | NAMS Newamsterdam Pharma Company | 9.6M | +0.0% | $324M | 2.8% |
| 9 | COAG Hemab Therapeutics Hldgs Inc | 7.8M | — | $287M | 2.5% |
| 10 | SEPN Septerna Inc | 7.0M | +0.0% | $234M | 2.0% |
| 11 | BCAX Bicara Therapeutics Inc | 7.3M | +0.0% | $215M | 1.9% |
| 12 | MLYS Mineralys Therapeutics Inc | 7.7M | +0.0% | $208M | 1.8% |
| 13 | GHRS Gh Research Plc | 7.6M | −0.5% | $205M | 1.8% |
| 14 | IRON Disc Medicine Inc | 2.5M | +0.0% | $179M | 1.6% |
| 15 | SGP Spyglass Pharma Inc | 8.0M | +0.0% | $179M | 1.6% |
| 16 | ARTV Artiva Biotherapeutics Inc | 18.0M | +82.2% | $174M | 1.5% |
| 17 | JANX Janux Therapeutics Inc | 11.2M | +0.0% | $172M | 1.5% |
| 18 | TSHA Taysha Gene Therapies Inc | 23.6M | +0.0% | $160M | 1.4% |
| 19 | BCRX Biocryst Pharmaceuticals Inc | 15.8M | +0.0% | $158M | 1.4% |
| 20 | WVE Wave Life Sciences Ltd | 27.0M | +0.0% | $157M | 1.4% |
| 21 | NUVALENT INC Nuvalent Inc | 1.2M | −50.8% | $154M | 1.3% |
| 22 | ABIVAX SA Abivax Sa | 1.1M | — | $151M | 1.3% |
| 23 | ORKA Oruka Therapeutics Inc | 1.6M | — | $148M | 1.3% |
| 24 | CLYM Climb Bio Inc | 11.3M | +0.0% | $147M | 1.3% |
| 25 | SLDB Solid Biosciences Inc | 12.0M | +28.9% | $120M | 1.0% |
| 26 | ZLAB Zai Lab Ltd | 5.7M | +0.6% | $109M | 0.9% |
| 27 | SPRY Ars Pharmaceuticals Inc | 10.9M | +0.0% | $87M | 0.8% |
| 28 | XNCR Xencor Inc | 5.3M | +7.7% | $85M | 0.7% |
| 29 | JBIO Jade Biosciences Inc | 3.7M | +0.0% | $82M | 0.7% |
| 30 | NTLA Intellia Therapeutics Inc | 4.5M | — | $77M | 0.7% |
| 31 | LBRX Lb Pharmaceuticals Inc | 2.2M | +0.0% | $72M | 0.6% |
| 32 | DFTX Definium Therapeutics Inc | 1.5M | — | $71M | 0.6% |
| 33 | ACRS Aclaris Therapeutics Inc | 12.7M | +87.0% | $67M | 0.6% |
| 34 | FDMT 4D Molecular Therapeutics In | 5.0M | +0.0% | $67M | 0.6% |
| 35 | SANA Sana Biotechnology Inc | 18.8M | — | $65M | 0.6% |
| 36 | DMRA Damora Therapeutics Inc | 2.4M | +0.0% | $62M | 0.5% |
| 37 | MNPR Monopar Therapeutics Inc | 667,207 | +0.0% | $62M | 0.5% |
| 38 | ABOS Acumen Pharmaceuticals Inc | 21.0M | +0.0% | $56M | 0.5% |
| 39 | GERN Geron Corp | 42.8M | −32.9% | $55M | 0.5% |
| 40 | RZLT Rezolute Inc | 9.4M | +2.9% | $49M | 0.4% |
| 41 | EVMN Evommune Inc | 3.5M | +0.0% | $46M | 0.4% |
| 42 | VOR Vor Biopharma Inc | 2.4M | −55.6% | $44M | 0.4% |
| 43 | IPSC Century Therapeutics Inc | 17.8M | +0.0% | $43M | 0.4% |
| 44 | AKTS Aktis Oncology Inc | 1.3M | −12.6% | $42M | 0.4% |
| 45 | BIOA Bioage Labs Inc | 1.7M | +1.3% | $41M | 0.4% |
| 46 | CCCC C4 Therapeutics Inc | 8.0M | +0.0% | $37M | 0.3% |
| 47 | MIRM Mirum Pharmaceuticals Inc | 318,554 | +0.0% | $37M | 0.3% |
| 48 | CAPR Capricor Therapeutics Inc | 1.5M | +0.0% | $36M | 0.3% |
| 49 | PEPG Pepgen Inc | 20.1M | +0.0% | $36M | 0.3% |
| 50 | PRLD Prelude Therapeutics Inc | 6.5M | — | $35M | 0.3% |